Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-08 4:02 pm Purchase | 13G | ASTROTECH CORP COM PAR $ ASTC | BML Investment Partners L.P. | 5,479,322 13.7% | 5,479,322 (New Position) | View |
2023-02-08 3:43 pm Purchase | 13G | METACRINE INC MTCR | BML Investment Partners L.P. | 6,767,458 15.9% | 278,493 (+4.29%) | View |
2023-02-08 3:23 pm Purchase | 13G | TILLYS INC TLYS | BML Investment Partners L.P. | 1,234,844 5.5% | 80,000 (+6.93%) | View |
2023-02-08 3:05 pm Sale | 13G | RICHARDSON ELECTRONICS LTD RELL | BML Investment Partners L.P. | 95,359 0.8% | -614,641 (-86.57%) | View |
2023-02-08 2:48 pm Purchase | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | BML Investment Partners L.P. | 858,256 5.95% | 96,401 (+12.65%) | View |
2023-02-08 2:38 pm Sale | 13G | RETRACTABLE TECHNOLOGIES INC. RVP | BML Investment Partners L.P. | 1,056,075 3.2% | -2,681,425 (-71.74%) | View |
2023-02-02 4:23 pm Purchase | 13G | SURROZEN INC SRZN | BML Investment Partners L.P. | 1,669,037 5.6% | 1,669,037 (New Position) | View |
2023-01-26 4:01 pm Purchase | 13G | CYTEIR THERAPEUTICS INC CYT | BML Investment Partners L.P. | 2,735,973 7.7% | 2,735,973 (New Position) | View |
2023-01-09 12:28 pm Purchase | 13G | DISC MEDICINE INC IRON | BML Investment Partners L.P. | 524,750 3.1% | 524,750 (New Position) | View |
2022-12-30 5:30 pm Purchase | 13G | PARDES BIOSCIENCES INC PRDS | BML Investment Partners L.P. | 4,867,984 7.8% | 4,867,984 (New Position) | View |
2022-12-08 12:08 pm Purchase | 13D | METACRINE INC MTCR | BML Investment Partners L.P. | 6,488,965 15.2% | 976,799 (+17.72%) | View |
2022-12-01 3:43 pm Purchase | 13G | GRAYBUG VISION INC GRAY | BML Investment Partners L.P. | 1,235,943 5.7% | 1,235,943 (New Position) | View |
2022-11-16 4:45 pm Purchase | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | BML Investment Partners L.P. | 6,440,000 19.4% | 6,440,000 (New Position) | View |
2022-10-26 5:59 pm Purchase | 13G | METACRINE INC MTCR | BML Investment Partners L.P. | 5,512,166 12.9% | 3,912,166 (+244.51%) | View |
2022-10-17 4:58 pm Purchase | 13G | TILLYS INC TLYS | BML Investment Partners L.P. | 1,154,844 5.4% | 417,344 (+56.59%) | View |
2022-08-25 12:04 pm Purchase | 13G | ASTROTECH CORP COM ASTC | BML Investment Partners L.P. | 5,479,322 10.8% | 2,892,006 (+111.78%) | View |
2022-08-16 08:22 am Purchase | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 1,461,364 7.2% | 118,973 (+8.86%) | View |
2022-07-07 08:22 am Purchase | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 1,342,391 9.1% | 22,391 (+1.70%) | View |
2022-06-07 4:41 pm Purchase | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners L.P. | 1,764,274 7% | 1,764,274 (New Position) | View |
2022-05-24 12:19 pm Purchase | 13D | FORTE BIOSCIENCES FBRX | BML Investment Partners L.P. | 1,320,000 8.94% | 431,243 (+48.52%) | View |